Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycemic control with GlucoTab using insulin glargine U300 in non-critically ill type 2 diabetes inpatients
2015-003669-27Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin glargine U300 in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Graz. Primary endpoint: Mean percentage of blood glucose measurements in target range. Started Sep 2015; status: completed.
02
Drugs
insulin glargine U300
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-003669-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003669-27.